MYH9 and cancer: ANHAK is involved in migration and invasion of cancer cells (Sudo et al. 2014), MYH9 could be a tumor suppressor via regulation of p53 (Schramek et al. 2014), while ENO1 is involved in Warburg effect and its targeting sensitizes cancer cells (Capello et al. 2016).